Alkermes, Inc. (NASDAQ:ALKS)

CAPS Rating: 4 out of 5

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

Recs

0
Player Avatar VoodooEconomist (36.60) Submitted: 4/14/2009 3:23:01 PM : Outperform Start Price: $8.71 ALKS Score: +24.82

Good PE - Like medical stocks

Featured Broker Partners


Advertisement